NCT06645249View on ClinicalTrials.gov

Evaluation of Cardioverter Capacity of Amiodarone Pre-electrical Cardioversion in Persistent Atrial Fibrillation

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

October 31, 2026

Conditions
Atrial Fibrillation (AF)
Interventions
DRUG

Amiodarone (Antiarrhythmic drug)

Comparing 2 regimes of amiodarone pre-electrical cardioversion witn ECG monitoring

Trial Locations (4)

15706

Hospital Clínico Universitario de Santiago, Santiago de Compostela

43204

Hospital Universitari de Sant Joan, Reus

08916

Hospital Universitari Germans Trias i Pujol, Badalona

08025

Hospital de la Santa Creu i Sant Pau, Barcelona

All Listed Sponsors
collaborator

Spanish Society of Cardiology

OTHER

collaborator

Sociedad Espanola de Cardiologia

UNKNOWN

lead

Institut Investigacio Sanitaria Pere Virgili

OTHER